Updates by Region

Recent in Updates by Region (page 26 of 29)

Malaysian Cosmetic Companies Encouraged by Trade Missions

Local cosmetic and beauty companies in Kuala Lumpur, Malaysia, are encouraged to assist with trade missions to help them in export their products.

Ingredient Review Update from CTFA

The Cosmetic Ingredient Review (CIR) board announced updated ingredient assessments in its April 4, 2006, report.

Aussie Regulations for Sunscreens May Risk Public Health
[April 6, 2006]

The Australian Society of Cosmetic Chemists (ASCC) warned in a recent press release that government changes to the regulation of moisturizers containing sunscreens could put the public at a higher risk of skin cancer...

Regulatory Review--United States and Canada: Update Online

Methods of registering cosmetic formulations are changing. This column will desribe the online registration processes for the United States and Canada.

EFfCI Publishes GMP Guide for Cosmetic Ingredients

The European Federation for Cosmetic Ingredients (EFfCI) released its Good Manufacturing Practice (GMP) Guide.

Exclusive! Comparatively Speaking: Drugs vs. Cosmetics by Tony O'Lenick

Tony O’Lenick asks: What is the difference between a drug and cosmetic? David Steinberg explains.

Ayurvedic Products Ruled Medicines, Not Cosmetics

Products containing medicinal content and aimed at curing certain ailments will be classified as medicaments and not cosmetics, according to a court ruling in New Delhi...

CTPA Says Review Paper on AP/Deo, Breast Cancer Should Not Cause Alarm

A recent paper calling for further research into the alleged link between aluminium salts in antiperspirants and breast cancer should not constitute alarm, said the CTPA.

AAD Responds to FDA Labeling Decision on Eczema Medications
[Feb. 21, 2006]

The American Academy of Dermatology (AAD) recently issued a statement in response to the U.S. Food and Drug Administration’s (FDA) decision that a black box warning be added to labels...

FDA Commissions Study of its Drug, Biologics Application Processes

The U.S. Food and Drug Administration (FDA) released a new report that examines the way the agency reviews applications for drugs and biologics that have not previously been approved by the FDA.

Dermatology Association Urges FDA to Postpone Program for Isotretinoin Patients

Patient safety while taking isotretinoin depends on the careful oversight of the prescriber, according to the American Academy of Dermatology Association.

Foamix Awarded American, Australian Patents for Delivery Technology

Foamix Ltd. announced it has received two separate patents for its delivery system/carrier technology.

Can't find what you're looking for? Try searching, or looking through past issues.